HIGHLIGHTS
- who: Nicky Daniels from the The RCT with a parallel design assessing the effect of multiple-dose OT administration in children with ASD was performed at the Leuven University Hospital (Belgium)The double-blind phase (phase I) was followed by a, week single-blind phase (phase II) during which all participants received intranasal OT. In both phases, OT administration effects were assessed immediately after the, week administration period (i.e., post-measurement , and, ) and at a follow-up session , weeks after cessation of the daily administrations (i.e., follow-up measurement , and, ). Please see Fig. A, for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.